Top Markets
#1 Tutorial Tutorial +68.67%
#2 Official Trump Official Trump +31.91%
#3 Mubarak Mubarak +23.30%
#4 Pump.fun Pump.fun +23.08%
#5 Unit Pump Unit Pump +23.08%
#6 Melania Meme Melania Meme +21.51%
#7 Stacks Stacks +20.26%
#8 MowCat MowCat +19.14%
#9 EXOD EXOD +18.93%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +18.48%
Coin of the day
Tutorial Tutorial
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

OPNT
Rang in aandelen #22841
Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical... Opiant Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on inventing remedies for both various addictions and drug overdoses. A key product in their current portfolio is NARCAN nasal spray, which provides a critical solution for counteracting opioid overdoses. Their development pipeline is robust, featuring several promising drug candidates designed to address further opioid overdose reversal needs, alcohol use disorders, acute cannabinoid overdose, and opioid use disorders. The company, which established itself in 2005, was initially named Lightlake Therapeutics Inc. before rebranding as Opiant Pharmaceuticals, Inc. in January 2016. Its corporate headquarters are located in Santa Monica, California.
Aandeelprijs
$20.65
Laatst gesynchroniseerd: 2023-03-01
Marktkapitalisatie
$82.52M
Verandering (1 dag)
-0.58%
Verandering (1 jaar)
0.00%
Land
US
Handel Opiant Pharmaceuticals, Inc. (OPNT)

Categorie

Healthcare
Aandelsplitsingen voor Opiant Pharmaceuticals, Inc. (OPNT)
Het aandeel Opiant Pharmaceuticals, Inc. (symbool: OPNT) heeft in totaal 0 splitsingen ondergaan.
De meest recente splitsing vond plaats op Aug 22, 2026.
Eén aandeel OPNT dat vóór Aug 22, 2026 werd gekocht, staat nu gelijk aan 0 aandelen OPNT.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
Niet genoeg gegevens voor de verstrekte datums.
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
Bedrijf Aantal aandelen splitsingen Cumulatieve vermenigvuldiging Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH